A. Mosbah, R. Kharrat, Z. Fajloun, J. G. Renisio, E. Blanc et al., A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel, Proteins, vol.40, pp.436-442, 2000.
URL : https://hal.archives-ouvertes.fr/pasteur-02019136

E. Estève, K. Mabrouk, A. Dupuis, S. Smida-rezgui, X. Altafaj et al., Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane, J. Biol. Chem, vol.280, pp.12833-12839, 2005.

N. Ram, S. Aroui, E. Jaumain, H. Bichraoui, K. Mabrouk et al., Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine, J. Biol. Chem, vol.283, pp.24274-24284, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00376511

S. Aroui, N. Ram, F. Appaix, M. Ronjat, A. Kenani et al., Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231, Pharm. Res, vol.26, pp.836-845, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00356481

S. Boisseau, K. Mabrouk, N. Ram, N. Garmy, V. Collin et al., Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor, Biochim. Biophys. Acta, vol.1758, pp.308-319, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00394156

A. Jayagopal, Y. R. Su, J. L. Blakemore, M. F. Linton, S. Fazio et al., Quantum dot mediated imaging of atherosclerosis, Nanotechnology, vol.20, p.165102, 2009.

C. Poillot, K. Dridi, H. Bichraoui, J. Pêcher, S. Alphonse et al., D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue, J. Biol. Chem, vol.285, pp.34168-34180, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00587800

N. Ram, N. Weiss, I. Texier-nogues, S. Aroui, N. Andreotti et al., Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells, J. Biol. Chem, vol.283, pp.27048-27056, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00355685

S. Aroui, S. Brahim, M. De-waard, J. Bréard, and A. Kenani, Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231, Cancer Lett, vol.285, pp.28-38, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410230

S. Aroui, S. Brahim, J. Hamelin, M. De-waard, J. Bréard et al., Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis, Apoptosis Int. J. Program. Cell Death, vol.14, pp.1352-1365, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00515338

S. Aroui, S. Brahim, M. D. Waard, A. Kenani, and . Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study, Biochem. Biophys. Res. Commun, vol.391, pp.419-425, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00587567

S. Aroui, D. Mili, S. Brahim, M. De-waard, and A. Kenani, Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase, Biochem. Biophys. Res. Commun, vol.396, pp.908-914, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00587561

C. Tisseyre, M. Ahmadi, S. Bacot, L. Dardevet, P. Perret et al., Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog, Biochim. Biophys. Acta, vol.1843, pp.2356-2364, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01022916

K. Mabrouk, N. Ram, S. Boisseau, F. Strappazzon, A. Rehaim et al., Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration, Biochim. Biophys. Acta, vol.1768, pp.2528-2540, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00378029

M. Ahmadi, S. Bacot, C. Poillot, M. Desruet, P. Perret et al., Selective mono-radioiodination and characterization of a cell-penetrating peptide: L-Tyr-Maurocalcine, Radiochim. Acta, vol.102, pp.1047-1057, 2014.

N. R. Maiti and W. K. Surewicz, The role of disulfide bridge in the folding and stability of the recombinant human prion protein, J. Biol. Chem, vol.276, pp.2427-2431, 2001.

B. S. Melnik, T. V. Povarnitsyna, A. S. Glukhov, T. N. Melnik, V. N. Uversky et al., SS-Stabilizing proteins rationally: Intrinsic disorder-based design of stabilizing disulphide bridges in GFP, J. Biomol. Struct. Dyn, vol.29, pp.815-824, 2012.

C. C. Huang, A. M. Friedman, G. V. Rayudu, P. Clark, and E. W. Fordham, In vivo stability and distribution of [131I]iodomethyl trimethylammonium chloride: Concise communication, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.21, pp.679-681, 1980.

K. O. Yu, L. Narayanan, D. R. Mattie, R. J. Godfrey, P. N. Todd et al., The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat, Toxicol. Appl. Pharmacol, vol.182, pp.148-159, 2002.